최원석
#감염질환#발열#예방접종#성인예방접종
|
학력
1996 .03 ~ 2002 .02 : 고려대학교 의과대학 졸업 학사
2004 .09 ~ 2006 .08 : 고려대학교 대학원 석사
2006 .09 ~ 2009 .02 : 고려대학교 대학원 박사
2004 .09 ~ 2006 .08 : 고려대학교 대학원 석사
2006 .09 ~ 2009 .02 : 고려대학교 대학원 박사
경력
2002 .03 ~ 2003 .02 : 고려대학교 의료원 인턴
2003 .03 ~ 2007 .02 : 고려대학교 의료원 내과 전공의
2007 .03 ~ 2008 .02 : 질병관리본부 예방접종관리팀 (책임)연구원
2008 .03 ~ 2009 .02 : 고려대학교 구로병원 감염내과 전임의
2009 .03 ~ 2011 .02 : 고려대학교 안산병원 감염내과 임상강사
2009 .09 ~ 2011 .02 : 고려대학교 의과대학 감염내과 겸임교수
2011 .03 ~ 2016 .02 : 고려대학교 의과대학 내과학교실(고려대학교 안산병원) 감염내과 조교수
2016 .03 ~ : 고려대학교 의과대학 내과학교실(고려대학교 안산병원) 감염내과 부교수
2012 ~ 2014 : 고려대학교 안산병원 감염내과 과장
2012 ~ 2014 : 고려대학교 안산병원 감염관리실장
2014 ~ 2017 : 고려대학교 안산병원 진료협력센터 부센터장
2014 ~ : 고려대학교 안산병원 임상시험심사위원회 위원(전문간사)
2007 ~ 2008 : 질병관리본부 질병예방센터 예방접종관리과 (책임)연구원
2009 ~ 2010 : 질병관리본부 예방접종관리과 신종인플루엔자 백신 실무자문단
2015 ~ 2017 : 대한화학요법학회(現 대한항균요법학회) 기획이사
2015 .06 ~ 2015 .07 : 경기도 메르스중점치료센터 부센터장
2017 .04 ~ 2017 .08 : 질병관리본부 예방접종피해보상 전문위원회 위원
2017 ~ 2018 : Visiting scholar in University of Pittsburgh
2012 ~ : 대한감염학회 성인예방접종위원회 위원(간사)
2013 ~ : 질병관리본부 예방접종전문위원회 분과위원
2016 ~ : 경기도 감염병관리지원단 자문위원
2016 ~ : 식품의약품안전처 중앙약사심의위원회 전문가
2017 ~ : 질병관리본부 즉각대응팀 민간전문가
2019 ~ : 대한항균요법학회 교육이사
2003 .03 ~ 2007 .02 : 고려대학교 의료원 내과 전공의
2007 .03 ~ 2008 .02 : 질병관리본부 예방접종관리팀 (책임)연구원
2008 .03 ~ 2009 .02 : 고려대학교 구로병원 감염내과 전임의
2009 .03 ~ 2011 .02 : 고려대학교 안산병원 감염내과 임상강사
2009 .09 ~ 2011 .02 : 고려대학교 의과대학 감염내과 겸임교수
2011 .03 ~ 2016 .02 : 고려대학교 의과대학 내과학교실(고려대학교 안산병원) 감염내과 조교수
2016 .03 ~ : 고려대학교 의과대학 내과학교실(고려대학교 안산병원) 감염내과 부교수
2012 ~ 2014 : 고려대학교 안산병원 감염내과 과장
2012 ~ 2014 : 고려대학교 안산병원 감염관리실장
2014 ~ 2017 : 고려대학교 안산병원 진료협력센터 부센터장
2014 ~ : 고려대학교 안산병원 임상시험심사위원회 위원(전문간사)
2007 ~ 2008 : 질병관리본부 질병예방센터 예방접종관리과 (책임)연구원
2009 ~ 2010 : 질병관리본부 예방접종관리과 신종인플루엔자 백신 실무자문단
2015 ~ 2017 : 대한화학요법학회(現 대한항균요법학회) 기획이사
2015 .06 ~ 2015 .07 : 경기도 메르스중점치료센터 부센터장
2017 .04 ~ 2017 .08 : 질병관리본부 예방접종피해보상 전문위원회 위원
2017 ~ 2018 : Visiting scholar in University of Pittsburgh
2012 ~ : 대한감염학회 성인예방접종위원회 위원(간사)
2013 ~ : 질병관리본부 예방접종전문위원회 분과위원
2016 ~ : 경기도 감염병관리지원단 자문위원
2016 ~ : 식품의약품안전처 중앙약사심의위원회 전문가
2017 ~ : 질병관리본부 즉각대응팀 민간전문가
2019 ~ : 대한항균요법학회 교육이사
논문
[SCI] (Immunogenicity and safety of an egg-based inactivated quadrivalent influenza vaccine (GC3110A) versus two inactivated trivalent influenza vaccines with alternate B strains: A phase Ⅲ randomized clinical trial in adults)
[SCI] (Direct effectiveness of pneumococcal polysaccharide vaccine against invasive pneumococcal disease and non-bacteremic pneumococcal pneumonia in elderly population in the era of pneumococcal conjugate vaccine: A case-control study)
[SCI] (The National Influenza Surveillance System of Korea.)
[SCI] (Safety and Effectiveness Analysis of Kivexa??(lamivudine/abacavir sulfate) in Human Immunodeficiency Virus Infected Korean Patients)
[SCI] (Immunogenicity and safety of a new live attenuated herpes zoster vaccine (NBP608) compared to Zostavax?? in healthy adults aged 50 years and older)
[국내논문] (Clinical and economic analysis of the 2009 H1N1 influenza pandemic among pregnant Korean women)
[SCI] (Characteristics of residual lymph nodes after six months of antituberculous therapy in HIV-negative individuals with cervical tuberculous lymphadenitis.)
[SCI] (Current status of indwelling urinary catheter utilization and catheter-associated urinary tract infection throughout hospital wards in Korea: A multicenter prospective observational study.)
[SCI] (Hospital-based Influenza Morbidity and Mortality (HIMM) Surveillance for A/H7N9 Influenza Virus Infection in Returning Travelers.)
[SCI] (Incidence and case fatality rates of community-acquired pneumonia and pneumococcal diseases among Korean adults: Catchment population-based analysis)
[SCI] (Immunogenicity and safety of a split-virion quadrivalent influenza vaccine in adults 18?60 years of age in the Republic of Korea.)
[SCI] (Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older)
[SCI] (Molecular genetic characteristics of influenza A virus clinically isolated during 2011-2016 influenza seasons in Korea)
[SCI] (Safety and Effectiveness of Peramivir in Korean Adult Influenza Patients: Prospective Observational Study Based on Post-Marketing Surveillance Data)
[SCI] (1. Significant circulation of influenza b viruses mismatching the recommended vaccine-lineage in South Korea, 2007?2014)
[SCI] (Adult invasive pneumococcal disease in the Republic of Korea: Risk medical conditions and mortality stratified by age group.)
[SCI] (Seroprevalence of Pertussis in Healthcare Workers without Adult Pertussis Vaccine Use at a University Hospital in Korea)
[SCI] (Trends and correlation between antibiotic usage and resistance pattern among hospitalized patients at university hospitals in Korea, 2004 to 2012: A nationwide multicenter study)
[SCI] (Effectiveness of influenza and pneumococcal polysaccharide vaccines against influenza-related outcomes including pneumonia and acute exacerbation of cardiopulmonary diseases: Analysis by dominant viral subtype and vaccine matching)
[SCI] (Aerosol transmission of severe fever with thrombocytopenia syndrome virus during resuscitation)
[SCI] (Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine and an MF59-adjuvanted influenza vaccine after concomitant vaccination in ≥60-year-old adults)
[SCI] (Comparison of immunogenicity and safety of an influenza vaccine administered concomitantly with a 13-valent pneumococcal conjugate vaccine or 23-valent polysaccharide pneumococcal vaccine in the elderly)
[SCI] (Disease burden of 2013-2014 seasonal influenza in adults in Korea)
[SCI] (Immunogenicity and safety of a cell culture-derived inactivated quadrivalent influenza vaccine (NBP607-QIV): A randomized, double-blind, multi-center, phase III clinical trial in adults and elderly subjects)
[SCI] (Randomized, double-blind, multi-center, phase III clinical trial to evaluate the immunogenicity and safety of MG1109 (egg-based pre-pandemic influenza A/H5N1 vaccine) in healthy adults)
[SCI] (Cost-effectiveness of pneumococcal vaccination strategies for the elderly in Korea)
[SCI] (Interim estimates of the effectiveness of the influenza vaccine against A(H3N2) influenza in adults in South Korea, 2016-2017 season)
[SCI] (Suboptimal effectiveness of 2011-2012 influenaza vaccine in adult Korean populations)
[SCI] (Chronic Cavitary Pulmonary Histoplasmosis in a Non-HIV and Immunocompromised Patient without Overseas Travel History)
[SCI] (Immunity and the burden of herpes zoster)
[SCI] (Case-control study of the effectiveness of the 2010-2011 seasonal influenza vaccine for prevention of laboratory-confirmed influenza virus infection in the Korean adult population)
[SCI] (Clinical practice guideline for antiviral treatment and chemoprophylaxis of seasonal influenza)
[SCI] (Skin and soft tissue infections: Experience over a five-year period and clinical usefulness of ultrasonography-guided gun biopsy-based culture)
[SCI] (Immunogenicity and Safety of the Influenza A/H1N1 2009 Inactivated Split-Virus Vaccine in Young and Older Adults: MF59-Adjuvanted Vaccine versus Nonadjuvanted Vaccine)
[SCI] (The Clinical Usefulness of the SD Bioline Influenza Antigen Test (R) for Detecting the 2009 Influenza A (H1N1) Virus)
[SCI] (Outbreak of Measles in the Republic of Korea, 2007: Importance of Nosocomial Transmission)
[SCI] (Clarithromycin and amikacin vs. clarithromycin and moxifloxacin for the treatment of post-acupuncture cutaneous infections due to Mycobacterium abscessus: a prospective observational study)
[SCI] (Effectiveness of the pandemic influenza A/H1N1 2009 monovalent vaccine in Korea)
[국외논문] (Timeliness of MMR vaccination and barriers to vaccination in preschool children)
[SCI] (Seroprevalence of Varicella-zoster Virus in Korea)
[SCI] (Liver Abscess and Empyema due to Lactococcus lactis cremoris)
[국내논문] 국내 침습성 폐렴알균 감염증의 임상양상
[SCI] (Disease Burden of Herpes zoster in Korea)
[국내논문] 2009년 발생한 신종인플루엔자 대유행에 대한 정책적 대응 평가
[국내논문] 신종인플루엔자 대유행에 대한 백신 대응 전략
[SCI] (Are gastric acid suppressants a risk factor for enteric peritonitis)
[국내논문] 우리나라의 백신 정책
[SCI] (Appropriateness of prophylactic antibiotic usage for major surgery in Korea)
[국내논문] 지속성 균혈증 및 진균혈증 - 위험인자 및 임상적 중요성
[국내논문] Vancomycin 내성 장구균에 의한 세균뇨의 역학과 임상적 중요성
[SCI] (CAPD peritonitis due to Brevundimonas vesicularis)
[SCI] (Direct effectiveness of pneumococcal polysaccharide vaccine against invasive pneumococcal disease and non-bacteremic pneumococcal pneumonia in elderly population in the era of pneumococcal conjugate vaccine: A case-control study)
[SCI] (The National Influenza Surveillance System of Korea.)
[SCI] (Safety and Effectiveness Analysis of Kivexa??(lamivudine/abacavir sulfate) in Human Immunodeficiency Virus Infected Korean Patients)
[SCI] (Immunogenicity and safety of a new live attenuated herpes zoster vaccine (NBP608) compared to Zostavax?? in healthy adults aged 50 years and older)
[국내논문] (Clinical and economic analysis of the 2009 H1N1 influenza pandemic among pregnant Korean women)
[SCI] (Characteristics of residual lymph nodes after six months of antituberculous therapy in HIV-negative individuals with cervical tuberculous lymphadenitis.)
[SCI] (Current status of indwelling urinary catheter utilization and catheter-associated urinary tract infection throughout hospital wards in Korea: A multicenter prospective observational study.)
[SCI] (Hospital-based Influenza Morbidity and Mortality (HIMM) Surveillance for A/H7N9 Influenza Virus Infection in Returning Travelers.)
[SCI] (Incidence and case fatality rates of community-acquired pneumonia and pneumococcal diseases among Korean adults: Catchment population-based analysis)
[SCI] (Immunogenicity and safety of a split-virion quadrivalent influenza vaccine in adults 18?60 years of age in the Republic of Korea.)
[SCI] (Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older)
[SCI] (Molecular genetic characteristics of influenza A virus clinically isolated during 2011-2016 influenza seasons in Korea)
[SCI] (Safety and Effectiveness of Peramivir in Korean Adult Influenza Patients: Prospective Observational Study Based on Post-Marketing Surveillance Data)
[SCI] (1. Significant circulation of influenza b viruses mismatching the recommended vaccine-lineage in South Korea, 2007?2014)
[SCI] (Adult invasive pneumococcal disease in the Republic of Korea: Risk medical conditions and mortality stratified by age group.)
[SCI] (Seroprevalence of Pertussis in Healthcare Workers without Adult Pertussis Vaccine Use at a University Hospital in Korea)
[SCI] (Trends and correlation between antibiotic usage and resistance pattern among hospitalized patients at university hospitals in Korea, 2004 to 2012: A nationwide multicenter study)
[SCI] (Effectiveness of influenza and pneumococcal polysaccharide vaccines against influenza-related outcomes including pneumonia and acute exacerbation of cardiopulmonary diseases: Analysis by dominant viral subtype and vaccine matching)
[SCI] (Aerosol transmission of severe fever with thrombocytopenia syndrome virus during resuscitation)
[SCI] (Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine and an MF59-adjuvanted influenza vaccine after concomitant vaccination in ≥60-year-old adults)
[SCI] (Comparison of immunogenicity and safety of an influenza vaccine administered concomitantly with a 13-valent pneumococcal conjugate vaccine or 23-valent polysaccharide pneumococcal vaccine in the elderly)
[SCI] (Disease burden of 2013-2014 seasonal influenza in adults in Korea)
[SCI] (Immunogenicity and safety of a cell culture-derived inactivated quadrivalent influenza vaccine (NBP607-QIV): A randomized, double-blind, multi-center, phase III clinical trial in adults and elderly subjects)
[SCI] (Randomized, double-blind, multi-center, phase III clinical trial to evaluate the immunogenicity and safety of MG1109 (egg-based pre-pandemic influenza A/H5N1 vaccine) in healthy adults)
[SCI] (Cost-effectiveness of pneumococcal vaccination strategies for the elderly in Korea)
[SCI] (Interim estimates of the effectiveness of the influenza vaccine against A(H3N2) influenza in adults in South Korea, 2016-2017 season)
[SCI] (Suboptimal effectiveness of 2011-2012 influenaza vaccine in adult Korean populations)
[SCI] (Chronic Cavitary Pulmonary Histoplasmosis in a Non-HIV and Immunocompromised Patient without Overseas Travel History)
[SCI] (Immunity and the burden of herpes zoster)
[SCI] (Case-control study of the effectiveness of the 2010-2011 seasonal influenza vaccine for prevention of laboratory-confirmed influenza virus infection in the Korean adult population)
[SCI] (Clinical practice guideline for antiviral treatment and chemoprophylaxis of seasonal influenza)
[SCI] (Skin and soft tissue infections: Experience over a five-year period and clinical usefulness of ultrasonography-guided gun biopsy-based culture)
[SCI] (Immunogenicity and Safety of the Influenza A/H1N1 2009 Inactivated Split-Virus Vaccine in Young and Older Adults: MF59-Adjuvanted Vaccine versus Nonadjuvanted Vaccine)
[SCI] (The Clinical Usefulness of the SD Bioline Influenza Antigen Test (R) for Detecting the 2009 Influenza A (H1N1) Virus)
[SCI] (Outbreak of Measles in the Republic of Korea, 2007: Importance of Nosocomial Transmission)
[SCI] (Clarithromycin and amikacin vs. clarithromycin and moxifloxacin for the treatment of post-acupuncture cutaneous infections due to Mycobacterium abscessus: a prospective observational study)
[SCI] (Effectiveness of the pandemic influenza A/H1N1 2009 monovalent vaccine in Korea)
[국외논문] (Timeliness of MMR vaccination and barriers to vaccination in preschool children)
[SCI] (Seroprevalence of Varicella-zoster Virus in Korea)
[SCI] (Liver Abscess and Empyema due to Lactococcus lactis cremoris)
[국내논문] 국내 침습성 폐렴알균 감염증의 임상양상
[SCI] (Disease Burden of Herpes zoster in Korea)
[국내논문] 2009년 발생한 신종인플루엔자 대유행에 대한 정책적 대응 평가
[국내논문] 신종인플루엔자 대유행에 대한 백신 대응 전략
[SCI] (Are gastric acid suppressants a risk factor for enteric peritonitis)
[국내논문] 우리나라의 백신 정책
[SCI] (Appropriateness of prophylactic antibiotic usage for major surgery in Korea)
[국내논문] 지속성 균혈증 및 진균혈증 - 위험인자 및 임상적 중요성
[국내논문] Vancomycin 내성 장구균에 의한 세균뇨의 역학과 임상적 중요성
[SCI] (CAPD peritonitis due to Brevundimonas vesicularis)
저서
알기 쉬운 항생제 처방
성인예방접종 3판
노년내과학
노인의학
항생제의 길잡이
인플루엔자
노인병학 제3판
성인예방접종 2판
성인예방접종 3판
노년내과학
노인의학
항생제의 길잡이
인플루엔자
노인병학 제3판
성인예방접종 2판
보도자료
美, 코로나19 치료제 '렘데시비르' 공식 인정…의미는
https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=101&oid=055&aid=0000811749
코로나19 '항체 형성' 확인…지속기간·방어력 등은 수수께끼
https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=102&oid=001&aid=0011565820
오늘부터 미국발 입국자도 모두 검사… 무증상 전파 막는다
https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=102&oid=005&aid=0001310615
https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=101&oid=055&aid=0000811749
코로나19 '항체 형성' 확인…지속기간·방어력 등은 수수께끼
https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=102&oid=001&aid=0011565820
오늘부터 미국발 입국자도 모두 검사… 무증상 전파 막는다
https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=102&oid=005&aid=0001310615
포스팅
영상자료
영상자료 내용이 없습니다.
발표자료
발표자료 내용이 없습니다.